Munich, Germany, 2 July 2026
MIG Capital, one of Germany’s leading venture capital firms, today announces the stock market debut of its portfolio company IQM Quantum Computers on Nasdaq in New York (WKN: IQMX). Trading on Nasdaq Helsinki will begin one day later. MIG Capital was among the founding investors of the Finnish-German scale-up, which is headquartered in Espoo and Munich, in 2018. Since then, a double-digit million euro amount has been invested in the leading European quantum computing company through several MIG funds.
Michael Motschmann, Managing Partner of MIG Capital, says: “We congratulate the entire team around Dr. Jan Goetz, Dr. Sierk Poetting and Dr. Sören Hein on this milestone on the path to becoming a European champion in this key industry.”
IQM and the US SPAC Real Asset Acquisition Corp. (RAAQ) had already announced their merger in February. A recent shareholders’ meeting of RAAQ approved the transaction, paving the way for today’s listing on Nasdaq. The transaction valued IQM at close to €1.6 billion before the stock market debut. In addition to MIG Capital AG through its MIG Fonds, almost 30 other renowned investors are invested in IQM.
IQM is the first leading European quantum computing company to be listed on a stock exchange. Michael Motschmann underlines the significance: “The successful move to the capital market underlines IQM’s technology leadership and operational excellence. From a European perspective, it is also an important building block for greater technological sovereignty.”
Like other quantum computing companies, IQM is working on computing power that could enable breakthroughs in medicine, materials research, AI, logistics, climate research and other future fields. Strong demand for quantum computing is also expected to be driven by digitalisation and the global AI boom.
IQM develops, manufactures and operates superconducting quantum processors across the full value chain, from in-house chip production to hardware, software and its own cloud platform. With 23 systems sold to 13 customers to date, IQM currently has the highest publicly communicated number of delivered on-premises systems worldwide. In 2025, IQM generated revenue of USD 36 million and had an order backlog of USD 67 million.
The MIG Fonds MIG 2, MIG 4, MIG 6, MIG 8, MIG 10, MIG 14 and MIG 17 are invested in IQM. Michael Motschmann adds: “We are proud that, together with our investors, we have been able to support and help shape IQM’s development over many years. This stock market debut is also their success.”
IQM is the latest in a series of IPOs supported by MIG Capital, including Mainz-based biotechnology company BioNTech. The MIG Fonds also hold shares in two further listed companies, Immatics (WKN: A2P72S) and AC Immune (WKN: A2AR5F).
-END-
About MIG Capital
MIG Capital is one of the leading German VC investors. Through its MIG Fonds, MIG invests in young deep tech and life sciences companies in German-speaking Europe and beyond. To date, the company has invested €800 million in approx. 60 start-ups. MIG portfolio companies develop innovations in areas including biopharmaceuticals, energy and environmental technologies, advanced computing, digitalization/IoT, medical technology, and digital health. The MIG investment portfolio currently consists of more than 30 companies.
MIG’s investment team is made up of a dedicated group of engineers, scientists, physicians, and entrepreneurs who use analytical and creative processes to assess the risks and opportunities of business models and technologies. Their reputation, experience, and network provide excellent access to companies, institutions and decision-makers to support the growth of their portfolio companies.
In recent years, MIG Capital has realized more than ten successful portfolio company sales, including Siltectra (to Infineon) and Hemovent (to MicroPort). It has placed several companies on the stock exchange including BRAIN, NFON, BioNTech, and Immatics.
For further information, please visit: www.mig.ag , www.mig-fonds.de or LinkedIn.
Contact
Michael Motschmann
Managing Partner of MIG Capital AG
mm@mig.ag
Media contact
Dr. Klaus Westermeier Medienbüro
+49-172-8433232
info@kwestermeier.de